Skip to content

Erasca, Inc. ERAS Total Liabilities & Equity

Total Liabilities & Equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Pfizer logo
PfizerPFE
$207.62B-0.2%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$2.25B-4.7%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$435.79M+58.9%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s total liabilities & equity?
Erasca, Inc. (ERAS) reported total liabilities & equity of $461.23M in Q1 2026.
How has Erasca, Inc.'s total liabilities & equity changed year-over-year?
Erasca, Inc.'s total liabilities & equity decreased by 2.1% year-over-year, from $471.24M to $461.23M.
What is the long-term trend for Erasca, Inc.'s total liabilities & equity?
Over 5 years (2020 to 2025), Erasca, Inc.'s total liabilities & equity has grown at a 26.0% compound annual growth rate (CAGR), from $124.83M to $396.15M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.